Loading chat...
IN SB0221
Bill
AI Summary
Summary of Indiana Senate Bill 221 (2018)
-
Defines "pain management clinic" as a facility primarily treating pain through prescribing controlled substances, excluding hospitals, educational institutions, hospices, surgical centers, and long-term care facilities.
-
Requires practitioners to check the INSPECT database before prescribing opioids or benzodiazepines on a phased timeline: January 1, 2019 for emergency departments and pain management clinics; January 1, 2020 for all hospital practitioners; January 1, 2021 for all practitioners.
-
Mandates that all practitioners authorized to prescribe controlled substances must be certified to receive INSPECT program information beginning January 1, 2019.
-
Allows dispensers to transmit prescription data to INSPECT via any board-approved electronic method, eliminating outdated requirements for computer diskettes and CD-ROMs.
-
Establishes a waiver process for practitioners who lack Internet access at their place of business to be exempted from the INSPECT database consultation requirement.
Legislative Description
INSPECT program. Allows a dispenser of ephedrine, pseudoephedrine, or a controlled substance to transmit certain information to the INSPECT program by any electronic method that meets specifications prescribed by the state board of pharmacy (board). Provides that, to the extent considered appropriate by the board, the INSPECT data base must be interoperable with other similar registries operated by federal and state governments. Requires the following practitioners to obtain information about a patient from the data base before prescribing an opioid or benzodiazepine to the patient: (1) A practitioner who has had the information from the data base integrated into the
Last Action
Public Law 194
3/22/2018